Bell palsy incidence higher with SARS-CoV-2 infection than vaccine
May 02, 2023
The review, however, showed a significantly increased incidence of Bell palsy in vaccine recipients versus those receiving placebo.
Biden administration may stop buying COVID-19 vaccines, treatments by fall
Aug 17, 2022
Tests, vaccines and treatments would be provided through the regular healthcare system.
Cardiac complications up after SARS-CoV-2 infection versus vaccines
Apr 06, 2022
“[T]he risks for these complications were higher after infection than after vaccination among males and females in all age groups,” the authors write.
One in nine may get delayed large local reaction after Moderna vaccine
Jun 10, 2022
A higher risk was seen among women and among individuals aged 30 to 69 years.
Moderna vaccine may shield more against breakthrough infections than Pfizer: study
Aug 12, 2021
The Mayo Clinic researchers found that in Minnesota last month, the Moderna vaccine was 76% effective at preventing a breakthrough infection, whereas the Pfizer vaccine was only 42% effective.
CDC, AMA urge Americans to make sure they are vaccinated against measles
Mar 19, 2024
Cases are rising in the United States and globally due to pockets of unvaccinated people.
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
Adverse events associated with BNT162b2 vaccination ID’d
Aug 27, 2021
Vaccination with the Pfizer–BioNTech mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an increased risk for myocarditis and lymphadenopathy, according...
mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
Adenoviral-based COVID-19 vaccines may up short-term CV risk
Aug 23, 2022
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.